^
No biomarker
Retinoblastoma
cyclophosphamide oral
Sensitive: A1 - Approval
BRD4 overexpression
Retinoblastoma
JQ-1
Sensitive: D – Preclinical
B4GALNT1 expression
Retinoblastoma
CAR-T immunotherapy
Sensitive: D – Preclinical
PRMT5 overexpression
Retinoblastoma
EPZ015666
Sensitive: D – Preclinical